• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by BioDelivery Sciences International Inc.

    3/28/22 12:15:08 AM ET
    $BDSI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BDSI alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: March 25, 2022
    Accession Number: 0001104659-22-037118
    Submission Type: POS AM
    CIK: 0001103021
    Company Name: BIODELIVERY SCIENCES INTERNATIONAL INC
    File Number: 333-232880
    Get the next $BDSI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BDSI

    DatePrice TargetRatingAnalyst
    2/15/2022$5.00 → $5.60Overweight → Neutral
    Piper Sandler
    1/21/2022$4.00 → $4.50Neutral
    HC Wainwright & Co.
    11/4/2021$6.00 → $4.50Buy → Neutral
    HC Wainwright & Co.
    8/5/2021$5.50 → $6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BDSI
    SEC Filings

    See more
    • SEC Form 15-12B filed by BioDelivery Sciences International Inc.

      15-12B - BIODELIVERY SCIENCES INTERNATIONAL INC (0001103021) (Filer)

      4/1/22 5:02:37 PM ET
      $BDSI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by BioDelivery Sciences International Inc.

      EFFECT - BIODELIVERY SCIENCES INTERNATIONAL INC (0001103021) (Filer)

      3/28/22 12:15:08 AM ET
      $BDSI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form S-8 POS filed by BioDelivery Sciences International Inc.

      S-8 POS - BIODELIVERY SCIENCES INTERNATIONAL INC (0001103021) (Filer)

      3/23/22 5:30:38 PM ET
      $BDSI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BDSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Watson W. Mark disposed of 90,663 shares, closing all direct ownership in the company to satisfy tax liability

      4 - BIODELIVERY SCIENCES INTERNATIONAL INC (0001103021) (Issuer)

      3/22/22 5:18:46 PM ET
      $BDSI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Vollins James (withholding tax)

      4 - BIODELIVERY SCIENCES INTERNATIONAL INC (0001103021) (Issuer)

      3/22/22 5:18:09 PM ET
      $BDSI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: Singh Vanila disposed of 35,851 shares, closing all direct ownership in the company to satisfy withholding tax

      4 - BIODELIVERY SCIENCES INTERNATIONAL INC (0001103021) (Issuer)

      3/22/22 5:17:22 PM ET
      $BDSI
      Biotechnology: Pharmaceutical Preparations
      Health Care